Evidence map›Paper›PMID 32279080›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2020

Using and improving distributed data networks to generate actionable evidence: the case of real-world outcomes in the Food and Drug Administration's Sentinel system.

Jeffrey S Brown, Judith C Maro, Michael Nguyen, Robert Ball

Abstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Trust in Observational Research.Journal of the American College of Cardiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Collaborative pharmacy research across integrated health systems: A purpose and promise for opportunities to study the complete medication-use process.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2025
    Article
  11. Assessing and improving research readiness in PCORnet®.Journal of clinical and translational science · 2025
    Article
  12. Article
  13. A general framework for developing computable clinical phenotype algorithms.Journal of the American Medical Informatics Association : JAMIA · 2024
    Article
  14. Centralized and Federated Models for the Analysis of Clinical Data.Annual review of biomedical data science · 2024
    Review
  15. Standards and frameworks.Journal of the American Medical Informatics Association : JAMIA · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The US Food and Drug Administration Sentinel System: a national resource for a learning health system.Journal of the American Medical Informatics Association : JAMIA · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeffrey S BrownDepartment of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
Judith C MaroDepartment of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.
Michael NguyenOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland, USA.
Robert BallOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland, USA.

Funding

FDA HHS HHSF223201400030I
6 · The paper itself

Abstract

The US Food and Drug Administration (FDA) Sentinel System uses a distributed data network, a common data model, curated real-world data, and distributed analytic tools to generate evidence for FDA decision-making. Sentinel system needs include analytic flexibility, transparency, and reproducibility while protecting patient privacy. Based on over a decade of experience, a critical system limitation is the inability to identify enough medical conditions of interest in observational data to a satisfactory level of accuracy. Improving the system's ability to use computable phenotypes will require an "all of the above" approach that improves use of electronic health data while incorporating the growing array of complementary electronic health record data sources. FDA recently funded a Sentinel System Innovation Center and a Community Building and Outreach Center that will provide a platform for collaboration across disciplines to promote better use of real-world data for decision-making.

Indexed as

Computer Communication NetworksLearning Health SystemProduct Surveillance, PostmarketingUnited States Food and Drug AdministrationElectronic Health RecordsUnited Statesdistributed networks, computable phenotypes, electronic health datadrug safety surveillancehealth outcomes

Identifiers

PMID32279080
PMCPMC7647264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.